Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock, Common Stock and Stockholders??? Equity (Deficit)

v3.23.2
Condensed Consolidated Statement of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock, Common Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Contingently Redeemable Convertible Common Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2021 [1]   22,959,000 0      
Temporary equity, balances at beginning of period at Dec. 31, 2021 [1]   $ 487,918 $ 0      
Increase (Decrease) in Temporary Equity [Roll Forward]            
Issuance of convertible common stock (in shares) [1]     550,000      
Issuance of convertible common stock [1]     $ 27,473      
Issuance of preferred stock and common stock upon exercise of warrants (in shares) [1]   34,000        
Issuance of preferred stock and common stock upon exercise of warrants [1]   $ 989        
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [1]   (22,993,000) (550,000)      
Convertible preferred stock and contingently redeemable common stock conversion [1]   $ (488,907) $ (27,473)      
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2022 [1]   0 0      
Temporary equity, balances at ending of period at Jun. 30, 2022   $ 0 [1] $ 0 [2]      
Balances at beginning of period (in shares) at Dec. 31, 2021 [1]       1,874,000    
Balances at beginning of period at Dec. 31, 2021 $ (456,279)     $ 0 [1] $ 33,864 $ (490,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of preferred stock and common stock upon exercise of warrants [1]       31,000    
Conversion of preferred stock warrant liability to common stock warrants 2,182       2,182  
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [1]       23,640,000    
Convertible preferred stock and contingently redeemable common stock conversion 516,380     $ 2 [1] 516,378  
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs (in shares) [1]       4,184,000    
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs 79,981       79,980  
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination (93,196)       (93,196)  
Issuance of Earn-Out Shares (in shares) [1]       2,800,000    
Issuance of Earn-Out Shares 1       1  
Issuance of Class A common stock issued to employees, net of withholding taxes (in shares) [1]       6,000    
Issuance of Class A common stock issued to employees, net of withholding taxes (96)       (96)  
Issuance of common stock upon exercise of stock options (in shares) [1]       41,000    
Issuance of common stock upon exercise of stock options 333       333  
Repurchase of early exercised options (in shares) [1]       (3,000)    
Vesting of early exercise of options 125       125  
Stock-based compensation 24,785       24,785  
Net loss (82,694)         (82,694)
Balances at ending of period (in shares) at Jun. 30, 2022 [1]       32,573,000    
Balances at ending of period at Jun. 30, 2022 (8,478)     $ 3 [1] 564,356 (572,837)
Temporary equity, balances at beginning of period (in shares) at Mar. 31, 2022 [2]   22,959,000 550,000      
Temporary equity, balances at beginning of period at Mar. 31, 2022 [2]   $ 487,918 $ 27,473      
Increase (Decrease) in Temporary Equity [Roll Forward]            
Issuance of preferred stock and common stock upon exercise of warrants (in shares) [2]   34,000        
Issuance of preferred stock and common stock upon exercise of warrants [2]   $ 989        
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [2]   (22,993,000) (550,000)      
Convertible preferred stock and contingently redeemable common stock conversion [2]   $ (488,907) $ (27,473)      
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2022 [1]   0 0      
Temporary equity, balances at ending of period at Jun. 30, 2022   $ 0 [1] $ 0 [2]      
Balances at beginning of period (in shares) at Mar. 31, 2022       1,891,000    
Balances at beginning of period at Mar. 31, 2022 (498,866)     $ 0 38,661 (537,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of preferred stock and common stock upon exercise of warrants       31,000    
Conversion of preferred stock warrant liability to common stock warrants 2,182       2,182  
Convertible preferred stock and contingently redeemable common stock conversion (in shares)       23,640,000    
Convertible preferred stock and contingently redeemable common stock conversion 516,380     $ 2 516,378  
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs (in shares)       4,184,000    
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs 79,981     $ 1 79,980  
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination (93,196)       (93,196)  
Issuance of Earn-Out Shares (in shares)       2,800,000    
Issuance of Earn-Out Shares 1       1  
Issuance of Class A common stock issued to employees, net of withholding taxes (in shares)       6,000    
Issuance of Class A common stock issued to employees, net of withholding taxes (96)       (96)  
Issuance of common stock upon exercise of stock options (in shares)       24,000    
Issuance of common stock upon exercise of stock options 162       162  
Repurchase of early exercised options (in shares)       (3,000)    
Stock-based compensation 20,284       20,284  
Net loss (35,310)         (35,310)
Balances at ending of period (in shares) at Jun. 30, 2022 [1]       32,573,000    
Balances at ending of period at Jun. 30, 2022 $ (8,478)     $ 3 [1] 564,356 (572,837)
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2022 0          
Temporary equity, balances at beginning of period at Dec. 31, 2022 $ 0          
Balances at beginning of period (in shares) at Dec. 31, 2022       35,571,000    
Balances at beginning of period at Dec. 31, 2022 $ 26,533     $ 4 604,387 (577,858)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Cancellation of Earn-Out Shares (in shares) (197,142)          
Balances at ending of period (in shares) at Mar. 31, 2023       35,749,000    
Balances at ending of period at Mar. 31, 2023 $ 27,700     $ 4 618,623 (590,927)
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2022 0          
Temporary equity, balances at beginning of period at Dec. 31, 2022 $ 0          
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2023 0          
Temporary equity, balances at ending of period at Jun. 30, 2023 $ 0          
Balances at beginning of period (in shares) at Dec. 31, 2022       35,571,000    
Balances at beginning of period at Dec. 31, 2022 $ 26,533     $ 4 604,387 (577,858)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares) 37,334     38,000    
Issuance of common stock upon exercise of stock options $ 71       71  
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)       926,000    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (1,272)       (1,272)  
Shares issued in connection with the Employee Stock Purchase Plan (in shares)       100,000    
Shares issued in connection with the Employee Stock Purchase Plan 213       213  
Cancellation of Earn-Out Shares (in shares)       (197,000)    
Reduction in transaction costs 9,609       9,609  
Payment in lieu of fractional shares in connection with reverse split (1)       (1)  
Stock-based compensation 9,924       9,924  
Net loss (23,936)         (23,936)
Balances at ending of period (in shares) at Jun. 30, 2023       36,438,000    
Balances at ending of period at Jun. 30, 2023 $ 21,141     $ 4 622,931 (601,794)
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2023 0          
Temporary equity, balances at ending of period at Jun. 30, 2023 $ 0          
Balances at beginning of period (in shares) at Mar. 31, 2023       35,749,000    
Balances at beginning of period at Mar. 31, 2023 27,700     $ 4 618,623 (590,927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon exercise of stock options (in shares)       2,000    
Issuance of common stock upon exercise of stock options 3       3  
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (in shares)       587,000    
Issuance of common stock upon settlement of restricted stock units, net of tax withholdings (916)       (916)  
Shares issued in connection with the Employee Stock Purchase Plan (in shares)       100,000    
Shares issued in connection with the Employee Stock Purchase Plan 213       213  
Payment in lieu of fractional shares in connection with reverse split (1)       (1)  
Stock-based compensation 5,009       5,009  
Net loss (10,867)         (10,867)
Balances at ending of period (in shares) at Jun. 30, 2023       36,438,000    
Balances at ending of period at Jun. 30, 2023 $ 21,141     $ 4 $ 622,931 $ (601,794)
[1] The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement
[2] The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement